Nessuna connessione a internet — viene mostrata la versione salvata della pagina.

Revolution Medici…

USUSD
← Allo screener

Revolution Medicines, Inc. (US:RVMD) — Biotechnology: Biological Products (No Diagnostic Substances). Numero di borse in cui sono quotate le azioni della società: 1. In questa pagina: prezzo e grafico, dividendi, principali azionisti e cronologia del numero di azioni.

Informazioni sull'azienda

Sito web
revmed.com
Relazioni con gli investitori
revmed.com/investors/
Settore
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Sede centrale
REDWOOD CITY, United States
Amministratore delegato
Dr. Mark A. Goldsmith M.D., Ph.D.
Dipendenti
883
Fondata
2014
Azioni in circolazione
214.34 Mln al 2026-07-31
Flottante
184.5 Mln
Capitalizzazione di mercato
43.24 Mld USD
Insider
1.85%
Investitori istituzionali
101.01%
Settore (SIC)
Biological Products, (No Diagnostic Substances)
ISIN
US76155X1000
LEI
549300JU3X0LBCQ65892
Descrizione

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Borse e ticker

BorsaTickerValutaPrezzoTipo
US USA StocksRVMDUSD200.87 +0.50%azioni ordinarie

Prezzo su 3 mesi

US:RVMD · USD
giorno di rialzo giorno di ribasso data di stacco del dividendo data di pagamentoPassa il mouse / tocca un giorno — prezzi di apertura, chiusura, massimo e minimo

Dividendi

Nessun pagamento di dividendi trovato (controllato 08.10.2026). Probabilmente la società non distribuisce dividendi.

Notizie di questa settimana

Ancora nessuna notizia dal sito della società.

pubblicità

Principali azionisti

DetentoreQuotaAzioniData del rapporto
Blackrock Inc.6.39%13.7 Mln2026-06-30
Farallon Capital Managem…6.32%13.55 Mln2026-06-30
FMR, LLC5.69%12.2 Mln2026-06-30
Baker Bros. Advisors, LP5.34%11.44 Mln2026-06-30
Jupiter Topco LLC5.01%10.74 Mln2026-06-30
Darwin Global Management…4.96%10.63 Mln2026-06-30
Vanguard Capital Managem…4.24%9.09 Mln2026-06-30
Vanguard Portfolio Manag…3.87%8.29 Mln2026-06-30
Nextech Invest, Ltd.3.55%7.6 Mln2026-06-30
VANGUARD INDEX FUNDS-Van…2.99%6.41 Mln2026-06-30
Paradigm Biocapital Advi…2.97%6.36 Mln2026-06-30
VANGUARD INDEX FUNDS-Van…2.16%4.63 Mln2026-06-30
Growth Fund of America1.38%2.96 Mln2026-06-30
VANGUARD INDEX FUNDS-Van…1.25%2.67 Mln2026-06-30
Fidelity Mt. Vernon Stre…1.15%2.47 Mln2026-07-31
BORISY ALEXIS (Director)≈1.09%2.34 Mln2026-06-18
VANGUARD INDEX FUNDS-Van…1.07%2.29 Mln2026-06-30
VANGUARD SPECIALIZED FUN…0.86%1.84 Mln2026-04-30
iShares Trust-iShares Bi…0.65%1.39 Mln2026-07-31
JPMorgan Trust II-JPMorg…0.54%1.17 Mln2026-06-30
iShares Trust-iShares Ru…0.51%1.1 Mln2026-07-31
GOLDSMITH MARK A (Chief…≈0.46%984 2382026-08-21
KELSEY STEPHEN MICHAEL (…≈0.14%291 8762026-09-11
HORN MARGARET A (Chief O…≈0.07%154 6472026-06-17
ANDERS JACK LEE (Chief F…≈0.06%123 2692026-06-24
WANG XIAOLIN (Officer)≈0.05%116 0632026-03-17
LIN WEI (Officer)≈0.05%101 3662026-03-17
HORNING SANDRA (Director…≈0.05%97 7652026-06-18
CISLINI JEFFREY TODD (Ge…≈0.03%55 9072026-08-21
SCHROEDER THILO (Directo…——2024-12-05